GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola-Zaire, Ebola-Sudan, Lassa, Marburg, Zika virus and malaria. The company was founded in June 1988 and is headquartered in Smyrna, GA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
19
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Geovax Labs Inc market cap is $985,460.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Geovax Labs Inc 52 week high is $270.66 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Geovax Labs Inc 52 week low is $1.51 as of November 22, 2026.
Geovax Labs Inc stock price today is $1.81.
Geovax Labs Inc stock price yesterday was $1.91.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Geovax Labs Inc's P/E ratio is -0.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Geovax Labs Inc P/B ratio is 0.0277.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Geovax Labs Inc 50-day moving average is $5.76.